Skip to main content
. 2022 Feb 4;33(3):e31. doi: 10.3802/jgo.2022.33.e31

Table 4. Complications and grade of complications.

Complications No Yes χ2/Fisher
No. (%) No. (%) p-value
Periods 0.447
P1 26 (41.3) 10 (37.0)
P2 37 (58.7) 17 (63.0)
Sequence 0.642
Primary CS 22 (34.9) 11 (40.7)
Interval CS 20 (31.7) 5 (18.5)
Final CS 12 (19.0) 6 (22.2)
Recurrence 9 (14.3) 5 (18.5)
Histology 0.926
High grade serous 48 (76.2) 20 (74.1)
Low grade serous 3 (4.8) 1 (3.7)
Others 12 (19.0) 6 (22.2)
ASA status 0.256
1 6 (9.5) 5 (18.5)
2 48 (76.2) 16 (59.3)
3 9 (14.3) 6 (22.2)
R0/≥R1 0.439
R0 51 (81.0) 23 (85.2)
≥R1 12 (19.0) 4 (14.8)
Rectal anastomosis 0.662
No 2 (3.2) 1 (3.7)
Yes 61 (96.8) 26 (96.3)
Stoma 0.045
No 30 (47.6) 7 (25.9)
Yes 33 (52.4) 20 (74.1)
Type stoma 0.345
Colostomy 4 (12.1) 4 (20.0)
Ileostomy 29 (87.9) 16 (80.0)
Surgeon 0.303
1 13 (20.6) 9 (33.3)
2 20 (31.7) 7 (25.9)
3 9 (14.3) 6 (22.2)
4 9 (14.3) 0 (0.0)
5 7 (11.1) 3 (11.1)
6 5 (7.9) 2 (7.4)
Stoma closure 0.334
No 10 (30.3) 8 (40.0)
Yes 23 (69.7) 12 (60.0)
HIPEC 0.414
No 58 (92.1) 26 (96.3)
Yes 5 (7.9) 1 (3.7)
BMI 0.297
<30 54 (85.7) 25 (92.6)
≥30 9 (14.3) 2 (7.4)
Age (yr) 0.036
≤50 5 (7.9) 7 (25.9)
51–74 48 (76.2) 14 (51.9)
≥75 10 (15.9) 6 (22.2)
Duration surgery (min) 0.572
≤350 33 (52.4) 14 (51.9)
>350 30 (47.6) 13 (48.1)

ASA, American Society of Anesthesiologists; BMI, body mass index; CS, caesarean section; HIPEC, hyperthermic intraperitoneal chemotherapy.